Logo image
Identification of Extremely Premature Infants at Low Risk for Early-Onset Sepsis
Journal article   Open access   Peer reviewed

Identification of Extremely Premature Infants at Low Risk for Early-Onset Sepsis

Karen M Puopolo, Sagori Mukhopadhyay, Nellie I Hansen, C Michael Cotten, Barbara J Stoll, Pablo J Sanchez, Edward F Bell, Abhik Das, Angelita M Hensman, Krisa P Van Meurs, …
Pediatrics (Evanston), Vol.140(5), e20170925
11/2017
DOI: 10.1542/peds.2017-0925
PMCID: PMC5654397
PMID: 28982710
url
https://europepmc.org/articles/pmc5654397View
Published (Version of record) Open Access

Abstract

Premature infants are at high risk of early-onset sepsis (EOS) relative to term infants, and most are administered empirical antibiotics after birth. We aimed to determine if factors evident at birth could be used to identify premature infants at lower risk of EOS. Study infants were born at 22 to 28 weeks' gestation in Neonatal Research Network centers from 2006 to 2014. EOS was defined by isolation of pathogenic species from blood or cerebrospinal fluid culture at ≤72 hours age. Infants were hypothesized as "low risk" for EOS when delivered via cesarean delivery, with membrane rupture at delivery, and absence of clinical chorioamnionitis. Frequency of prolonged antibiotics (≥5 days) was compared between low-risk infants and all others. Risks of mortality, EOS, and other morbidities were assessed by using regression models adjusted for center, race, antenatal steroid use, multiple birth, sex, gestation, and birth weight. Of 15 433 infants, 5759 (37%) met low-risk criteria. EOS incidence among infants surviving >12 hours was 29 out of 5640 (0.5%) in the low-risk group versus 209 out of 8422 (2.5%) in the comparison group (adjusted relative risk = 0.24 [95% confidence interval, 0.16-0.36]). Low-risk infants also had significantly lower combined risk of EOS or death ≤12 hours. Prolonged antibiotics were administered to 34% of low-risk infants versus 47% of comparison infants without EOS. Delivery characteristics of extremely preterm infants can be used to identify those with significantly lower incidence of EOS. Recognition of differential risk may help guide decisions to limit early antibiotic use among approximately one-third of these infants.
Registries Adult Anti-Bacterial Agents - therapeutic use Female Humans Infant, Extremely Premature Infant, Newborn Infant, Premature, Diseases - diagnosis Infant, Premature, Diseases - drug therapy Infant, Premature, Diseases - mortality Male Risk Factors Sepsis - diagnosis Sepsis - drug therapy Sepsis - mortality Young Adult

Details

Metrics

Logo image